Areteia

Developer of therapeutics for eosinophilic asthma

placeDurham, North Carolina, United States calendar_todayFounded 2022 groups19 employees language areteiatx.com

Registered entities

Social engagement

Social engagement: 2.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Bain Capital Life Sciences.

Investor typeCountShare
Venture capital660%
Private equity110%
Other / undisclosed330%

Recent activity

8 Sep 2025
Event
European Respiratory Society Congress 2025
14 Aug 2025
Event
European Respiratory Society Congress
Coming soon